Inorganic Polyphosphate in Hematolymphoid Malignancies: Biological Rationale and Emerging Research Gaps
Biomolecules · 16.07.2026 · 16 (7) · 1036
DOI: 10.3390/biom16071036 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 16.07.2026. Verfasst von Francisco García-Domínguez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Management Unit in Pathology, Puerta del Mar University Hospital, 11009 Cadiz, Spain. Hauptthemen laut MEDLINE: Polyphosphates, Hematologic Neoplasms. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of University, Research and Innovation of the Regional Government of Andalusia, Programa Operativo FEDER Andalucia 2021-2027; and the Consejería de Universidad, Investigación e Innovación de la Junta de Andalucía, Consejería de Universidad, Investigación e Innovación de la Junta de Andalucía.
Abstract (Originalsprache)
Inorganic polyphosphates (polyP) are linear phosphate polymers that play essential functions in human physiology, such as coagulation and inflammation. Despite their recognized participation in solid tumor progression, there are few data on hematolymphoid malignancies. Here, we conducted a narrative review of studies investigating polyP functions in mammalian biology, coagulation, and hematologic systems, focusing on research gaps in hematological oncology. PolyP modulates coagulation cascades, platelet activation, and cellular metabolism. In tumors, polyP has been reported to modulate immune responses and apoptosis in several experimental systems. Emerging data suggest participation in leukemic signaling and the bone marrow microenvironment. Direct evidence linking polyP to hematolymphoid neoplasms is scarce. Being biologically plausible, it represents a promising and largely unexplored area of research and an excellent opportunity for novel therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Management Unit in Pathology, Puerta del Mar University Hospital, 11009 Cadiz, Spain.
- Clinical and Translational Research in Hematology Group (EM-34), Biomedical Research and Innovation Institute of Cadiz (INiBICA), Puerta del Mar University Hospital, 11009 Cadiz, Spain.
- Department of Biomedicine, Biotechnology and Public Health, Faculty of Medicine, University of Cadiz, 11003 Cadiz, Spain.
- Department of Medicine and Surgery, Faculty of Medicine, University of Cadiz, 11003 Cadiz, Spain.
ORCID-Profile: Francisco García-Domínguez, Cecilia Fernandez-Ponce, Antonio Santisteban-Espejo, Felix A Ruiz
Förderung
- Department of University, Research and Innovation of the Regional Government of Andalusia
- Programa Operativo FEDER Andalucia 2021-2027; and the Consejería de Universidad, Investigación e Innovación de la Junta de Andalucía
- Consejería de Universidad, Investigación e Innovación de la Junta de Andalucía
- Programa Operativo FEDER Andalucia
Zitieren
APA
García-Domínguez, F., Fernandez-Ponce, C., Salb-Pernas, C., Santisteban-Espejo, A., & Ruiz, F. A. (2026). Inorganic Polyphosphate in Hematolymphoid Malignancies: Biological Rationale and Emerging Research Gaps. Biomolecules, 16(7), 1036. https://doi.org/10.3390/biom16071036
Vancouver
García-Domínguez F, Fernandez-Ponce C, Salb-Pernas C, Santisteban-Espejo A, Ruiz FA. Inorganic Polyphosphate in Hematolymphoid Malignancies: Biological Rationale and Emerging Research Gaps. Biomolecules. 2026;16(7):1036. doi:10.3390/biom16071036
BibTeX
@article{GarcaDomnguez2026,
author = {García-Domínguez, Francisco and Fernandez-Ponce, Cecilia and Salb-Pernas, Carlota and Santisteban-Espejo, Antonio and Ruiz, Felix A},
title = {Inorganic Polyphosphate in Hematolymphoid Malignancies: Biological Rationale and Emerging Research Gaps},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {7},
pages = {1036},
doi = {10.3390/biom16071036}
}
EUVIMED